NARACHI MICHAEL
Insider CIK 1380022 · CLDN Director · OREX President and CEO, Director · RARE Director · AMAG Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| RARE Ultragenyx Pharmaceutical | A Award deriv | 2026-05-14 | 2026-05-18 | 14,058 | — | $0 | 14,058 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award | 2026-05-14 | 2026-05-18 | 7,751 | — | $0 | 40,441 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award deriv | 2025-05-15 | 2025-05-19 | 10,787 | — | $0 | 10,787 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award | 2025-05-15 | 2025-05-19 | 5,740 | — | $0 | 32,690 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award deriv | 2024-06-18 | 2024-06-20 | 9,900 | — | $0 | 9,900 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award | 2024-06-18 | 2024-06-20 | 5,345 | — | $0 | 26,950 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award deriv | 2023-06-07 | 2023-06-09 | 7,110 | — | $0 | 7,110 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award | 2023-06-07 | 2023-06-09 | 3,860 | — | $0 | 21,605 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award deriv | 2022-06-24 | 2022-06-28 | 6,245 | — | $0 | 6,245 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award | 2022-06-24 | 2022-06-28 | 3,300 | — | $0 | 17,745 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award deriv | 2021-06-24 | 2021-06-28 | 4,125 | — | $0 | 4,125 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award | 2021-06-24 | 2021-06-28 | 2,145 | — | $0 | 14,445 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award deriv | 2020-06-26 | 2020-06-30 | 4,250 | — | $0 | 4,250 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award | 2020-06-26 | 2020-06-30 | 2,550 | — | $0 | 12,300 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award deriv | 2019-06-11 | 2019-06-13 | 5,000 | — | $0 | 5,000 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award | 2019-06-11 | 2019-06-13 | 3,000 | — | $0 | 9,750 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award deriv | 2018-06-19 | 2018-06-20 | 5,000 | — | $0 | 5,000 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award | 2018-06-19 | 2018-06-20 | 3,000 | — | $0 | 6,750 | SEC↗ |
| OREX Orexigen Therapeutics, Inc | A Award deriv | 2017-10-13 | 2017-10-17 | 252,000 | — | $0 | 252,000 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award deriv | 2017-06-22 | 2017-06-22 | 3,750 | — | $0 | 3,750 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award | 2017-06-22 | 2017-06-22 | 1,875 | — | $0 | 3,750 | SEC↗ |
| OREX Orexigen Therapeutics, Inc | A Award | 2017-05-31 | 2017-06-02 | 626 | $1.55 | $970 | 8,356 | SEC↗ |
| OREX Orexigen Therapeutics, Inc | A Award deriv | 2017-02-03 | 2017-02-07 | 315,000 | — | $0 | 315,000 | SEC↗ |
| OREX Orexigen Therapeutics, Inc | A Award deriv | 2017-02-03 | 2017-02-07 | 157,500 | — | $0 | 157,500 | SEC↗ |
| OREX Orexigen Therapeutics, Inc | A Award | 2016-11-30 | 2016-12-02 | 802 | $1.67 | $1.3K | 6,312 | SEC↗ |
| OREX Orexigen Therapeutics, Inc | A Award deriv | 2016-07-12 | 2016-07-14 | 525,000 | — | $0 | 525,000 | SEC↗ |
| OREX Orexigen Therapeutics, Inc | A Award deriv | 2016-07-12 | 2016-07-14 | 105,000 | — | $0 | 105,000 | SEC↗ |
| OREX Orexigen Therapeutics, Inc | A Award deriv | 2016-07-12 | 2016-07-14 | 63,000 | — | $0 | 63,000 | SEC↗ |
| OREX Orexigen Therapeutics, Inc | A Award deriv | 2016-07-12 | 2016-07-14 | 315,000 | — | $0 | 315,000 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award deriv | 2016-06-09 | 2016-06-14 | 3,750 | — | $0 | 3,750 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award | 2016-06-09 | 2016-06-14 | 1,875 | — | $0 | 1,875 | SEC↗ |
| OREX Orexigen Therapeutics, Inc | A Award | 2016-05-31 | 2016-06-02 | 8,777 | $0.34 | $3.0K | 69,285 | SEC↗ |
| OREX Orexigen Therapeutics, Inc | A Award deriv | 2016-02-02 | 2016-02-04 | 800,000 | — | $0 | 800,000 | SEC↗ |
| OREX Orexigen Therapeutics, Inc | A Award deriv | 2016-02-02 | 2016-02-04 | 700,000 | — | $0 | 700,000 | SEC↗ |
| OREX Orexigen Therapeutics, Inc | A Award | 2015-11-30 | 2016-02-04 | 1,761 | $2.03 | $3.6K | 60,508 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award deriv | 2015-06-18 | 2015-06-22 | 7,500 | — | $0 | 7,500 | SEC↗ |
| CLDN Celladon Corp | A Award deriv | 2015-06-04 | 2015-06-05 | 10,000 | — | $0 | 50,000 | SEC↗ |
| OREX Orexigen Therapeutics, Inc | A Award | 2015-05-29 | 2016-02-04 | 721 | $4.17 | $3.0K | 58,747 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award deriv | 2015-02-20 | 2015-02-24 | 17,500 | — | $0 | 17,500 | SEC↗ |
| OREX Orexigen Therapeutics, Inc | A Award deriv | 2015-02-03 | 2015-02-05 | 635,150 | — | $0 | 635,150 | SEC↗ |
| OREX Orexigen Therapeutics, Inc | P Buy | 2014-09-15 | 2014-09-15 | 50,000 | $4.78 | $239.0K | 58,026 | SEC↗ |
| CLDN Celladon Corp | A Award deriv | 2014-05-20 | 2014-05-21 | 10,000 | — | $0 | 10,000 | SEC↗ |
| OREX Orexigen Therapeutics, Inc | A Award deriv | 2014-02-07 | 2014-02-11 | 673,500 | — | $0 | 673,500 | SEC↗ |
| CLDN Celladon Corp | P Buy | 2014-02-04 | 2014-02-06 | 62,500 | $8.00 | $500.0K | 62,500 | SEC↗ |
| OREX Orexigen Therapeutics, Inc | A Award | 2013-11-29 | 2014-02-11 | 3,980 | $5.34 | $21.3K | 3,980 | SEC↗ |
| AMAG AMAG PHARMACEUTICALS INC. | A Award deriv | 2013-05-23 | 2013-05-24 | 7,600 | — | $0 | 7,600 | SEC↗ |
| AMAG AMAG PHARMACEUTICALS INC. | A Award | 2013-05-23 | 2013-05-24 | 3,800 | — | $0 | 23,900 | SEC↗ |
| OREX Orexigen Therapeutics, Inc | A Award deriv | 2013-02-15 | 2013-02-19 | 555,000 | — | $0 | 555,000 | SEC↗ |
| OREX Orexigen Therapeutics, Inc | M Exercise deriv | 2012-07-17 | 2012-07-19 | 25,762 | — | $0 | 1,774,238 | SEC↗ |
| OREX Orexigen Therapeutics, Inc | M Exercise deriv | 2012-07-17 | 2012-07-19 | 124,238 | — | $0 | 1,761,562 | SEC↗ |
| OREX Orexigen Therapeutics, Inc | S Sale | 2012-07-17 | 2012-07-19 | 124,238 | $7.66 | $951.7K | 0 | SEC↗ |
| OREX Orexigen Therapeutics, Inc | M Exercise | 2012-07-17 | 2012-07-19 | 124,238 | $1.66 | $206.2K | 124,238 | SEC↗ |
| OREX Orexigen Therapeutics, Inc | M Exercise | 2012-07-17 | 2012-07-19 | 25,762 | $1.70 | $43.8K | 25,762 | SEC↗ |
| OREX Orexigen Therapeutics, Inc | S Sale | 2012-07-17 | 2012-07-19 | 25,762 | $7.66 | $197.3K | 0 | SEC↗ |
| OREX Orexigen Therapeutics, Inc | M Exercise deriv | 2012-07-13 | 2012-07-13 | 147,100 | — | $0 | 1,885,800 | SEC↗ |
| OREX Orexigen Therapeutics, Inc | M Exercise | 2012-07-13 | 2012-07-13 | 147,100 | $1.66 | $244.2K | 147,100 | SEC↗ |
| OREX Orexigen Therapeutics, Inc | S Sale | 2012-07-13 | 2012-07-13 | 147,100 | $6.70 | $985.6K | 0 | SEC↗ |
| OREX Orexigen Therapeutics, Inc | M Exercise deriv | 2012-07-12 | 2012-07-13 | 2,900 | — | $0 | 2,032,900 | SEC↗ |
| OREX Orexigen Therapeutics, Inc | S Sale | 2012-07-12 | 2012-07-13 | 2,900 | $6.66 | $19.3K | 0 | SEC↗ |
| OREX Orexigen Therapeutics, Inc | M Exercise | 2012-07-12 | 2012-07-13 | 2,900 | $1.66 | $4.8K | 2,900 | SEC↗ |
| OREX Orexigen Therapeutics, Inc | M Exercise deriv | 2012-06-29 | 2012-06-29 | 125,000 | — | $0 | 2,035,800 | SEC↗ |
| OREX Orexigen Therapeutics, Inc | S Sale | 2012-06-29 | 2012-06-29 | 125,000 | $6.08 | $760.0K | 0 | SEC↗ |
| OREX Orexigen Therapeutics, Inc | M Exercise | 2012-06-29 | 2012-06-29 | 125,000 | $1.66 | $207.5K | 125,000 | SEC↗ |
| OREX Orexigen Therapeutics, Inc | M Exercise deriv | 2012-06-28 | 2012-06-29 | 100,000 | — | $0 | 2,160,800 | SEC↗ |
| OREX Orexigen Therapeutics, Inc | M Exercise | 2012-06-28 | 2012-06-29 | 100,000 | $1.66 | $166.0K | 100,000 | SEC↗ |
| OREX Orexigen Therapeutics, Inc | S Sale | 2012-06-28 | 2012-06-29 | 100,000 | $5.66 | $566.0K | 0 | SEC↗ |
| AMAG AMAG PHARMACEUTICALS INC. | P Buy | 2012-05-25 | 2012-05-29 | 5,500 | — | $0 | 7,500 | SEC↗ |
| AMAG AMAG PHARMACEUTICALS INC. | P Buy | 2012-05-24 | 2012-05-29 | 2,000 | $13.55 | $27.1K | 2,000 | SEC↗ |
| AMAG AMAG PHARMACEUTICALS INC. | A Award deriv | 2012-05-23 | 2012-05-25 | 7,600 | — | $0 | 7,600 | SEC↗ |
| AMAG AMAG PHARMACEUTICALS INC. | A Award deriv | 2012-05-23 | 2012-05-25 | 3,800 | — | $0 | 3,800 | SEC↗ |
| OREX Orexigen Therapeutics, Inc | A Award deriv | 2012-01-25 | 2012-01-26 | 900,000 | — | $0 | 900,000 | SEC↗ |